Seres Therapeutics Inc
Open
SectorHealthcare
4.56 -2.15
Overview
Share price change
24h
Min
4.55
Max
4.78
Income | 24M 4.6M |
|---|---|
Sales | 378K 736K |
P/E Sector Avg | 11.652 56.597 |
EPS | -1.5 |
Profit margin | 622.418 |
Employees | 66 |
EBITDA | -2.1M -21M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +259.41% upside |
Next Earnings | 4 lis 2026 |
|---|
Market Cap | 8.7M 57M |
|---|---|
Previous open | 6.71 |
Previous close | 4.56 |
News Sentiment
By Acuity
45%
55%
100 / 339 Ranking in Healthcare
Seres Therapeutics Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Seres Therapeutics Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 17 USD 259.41%
High 22 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$